Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N C Jones

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
European Journal of Pharmacology|August 24, 2006
Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist propertiesMartyn D Wood, Claire Scott, Kirsten Clarke, et al.
Journal of Proteome Research|August 29, 2009
Analyzing the effects of psychotropic drugs on metabolite profiles in rat brain using 1H NMR spectroscopyGerard A McLoughlin, Dan Ma, Tsz M Tsang, et al.
Behavioural Pharmacology|November 21, 2008
Selective dopamine D4 receptor agonist (A-412997) improves cognitive performance and stimulates motor activity without influencing reward-related behaviour in ratMarie L Woolley, Kerry A Waters, Charlie Reavill, et al.
Oncogene|November 24, 2015
p53 mutations cooperate with oncogenic Kras to promote adenocarcinoma from pancreatic ductal cellsJ M Bailey, A M Hendley, K J Lafaro, et al.
Epilepsia|January 14, 2010
Potentiation of the anticonvulsant efficacy of sodium channel inhibitors by an NK1-receptor antagonist in the ratMikhail Kalinichev, Andrea Bradford, Silvia Bison, et al.
CNS & Neurological Disorders Drug Targets|August 22, 2006
Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockadeMartyn D Wood, Claire Scott, Kirsten Clarke, et al.
The British Journal of Psychiatry : the Journal of Mental Science|May 17, 2018
Treatment-resistant depression and peripheral C-reactive proteinSamuel R Chamberlain, Jonathan Cavanagh, Peter de Boer, et al.
The Journal of Physical Chemistry. A|July 15, 2015
Electronic State Spectroscopy of Halothane As Studied by ab Initio Calculations, Vacuum Ultraviolet Synchrotron Radiation, and Electron Scattering MethodsF Ferreira da Silva, D Duflot, S V Hoffmann, et al.
Psychopharmacology|September 17, 2008
Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the ratM L Woolley, K A Waters, J E Gartlon, et al.
British Journal of Pharmacology|December 24, 2016
Pharmacological characterization of N-[(2S)-5-(6-fluoro-3-pyridinyl)-2, 3-dihydro-1H-inden-2-yl]-2-propanesulfonamide: a novel, clinical AMPA receptor positive allosteric modulatorSimon E Ward, Paul Beswick, Novella Calcinaghi, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
European Journal of Pharmacology|August 24, 2006
Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist propertiesMartyn D Wood, Claire Scott, Kirsten Clarke, et al.
Journal of Proteome Research|August 29, 2009
Analyzing the effects of psychotropic drugs on metabolite profiles in rat brain using 1H NMR spectroscopyGerard A McLoughlin, Dan Ma, Tsz M Tsang, et al.
Behavioural Pharmacology|November 21, 2008
Selective dopamine D4 receptor agonist (A-412997) improves cognitive performance and stimulates motor activity without influencing reward-related behaviour in ratMarie L Woolley, Kerry A Waters, Charlie Reavill, et al.
Oncogene|November 24, 2015
p53 mutations cooperate with oncogenic Kras to promote adenocarcinoma from pancreatic ductal cellsJ M Bailey, A M Hendley, K J Lafaro, et al.
Epilepsia|January 14, 2010
Potentiation of the anticonvulsant efficacy of sodium channel inhibitors by an NK1-receptor antagonist in the ratMikhail Kalinichev, Andrea Bradford, Silvia Bison, et al.
CNS & Neurological Disorders Drug Targets|August 22, 2006
Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockadeMartyn D Wood, Claire Scott, Kirsten Clarke, et al.
The British Journal of Psychiatry : the Journal of Mental Science|May 17, 2018
Treatment-resistant depression and peripheral C-reactive proteinSamuel R Chamberlain, Jonathan Cavanagh, Peter de Boer, et al.
The Journal of Physical Chemistry. A|July 15, 2015
Electronic State Spectroscopy of Halothane As Studied by ab Initio Calculations, Vacuum Ultraviolet Synchrotron Radiation, and Electron Scattering MethodsF Ferreira da Silva, D Duflot, S V Hoffmann, et al.
Psychopharmacology|September 17, 2008
Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the ratM L Woolley, K A Waters, J E Gartlon, et al.
British Journal of Pharmacology|December 24, 2016
Pharmacological characterization of N-[(2S)-5-(6-fluoro-3-pyridinyl)-2, 3-dihydro-1H-inden-2-yl]-2-propanesulfonamide: a novel, clinical AMPA receptor positive allosteric modulatorSimon E Ward, Paul Beswick, Novella Calcinaghi, et al.
Pageof 13